Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NorthStar Medical Radioisotopes is a commercial-stage leader in the U.S. for producing key medical radioisotopes such as molybdenum‑99/technetium‑99m for diagnostics and copper‑67/actinium‑225 for therapeutic use. The company has established itself as the first U.S. commercial-scale producer of non-carrier-added actinium‑225 using environmentally preferable technology. It also operates a full-service radiopharmaceutical CDMO unit to support biopharma development programs[6][8][9].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North Star Energy.